Collective efficacy: A protective factor for sexual minority men during the U.S. mpox outbreak.

ABSTRACT:

Objectives

Collective efficacy is an understudied potential protective factor for health behavior change. This study extends previous research on HIV and COVID-19 infection to test associations with mpox vaccination and symptoms of depression and anxiety among sexual minority men during the mpox outbreak.

Method

Between July 28, 2022 and September 22, 2022, adult cisgender sexual minority men (n = 2,614) were recruited from social networking applications and completed a cross-sectional online survey that assessed collective efficacy (united action), mpox vaccination, and symptoms of anxiety and depression.

Results

In multivariable regression models, united action was positively associated with having received at least one dose of the mpox vaccine (OR = 1.025, p = .04)

SUBMITTER: Cain D 

PROVIDER: S-EPMC12036798 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature